Back to results
US 2012/0251448 A1Published application
Compounds for Use in the Detection of Neurodegenerative Diseases
OwnerFranz F. Hefti, Geoffrey Golding +8inventors
InventorsFranz F. Hefti, Geoffrey Golding, Ximin Li, Seok-Rye Choi, Luke Esposito, Marisa-Claire Yadon, Joel Cummings, F. Michael Hudson, Thomas Lake, Alan D. Snow
Life of this patent
Estimating the term…
Abstract
Provided are the use of the disclosed compounds as imaging agents and methods for in vivo imaging and detection of pathological characteristics unique to synuclein diseases, such as Parkinson's disease.
Claims11
A method of in vivo imaging of α-synuclein aggregates, comprising introducing into a mammal a detectable amount of a compound selected from
- which has been labeled with a detectable substance, allowing a sufficient time period for the labeled compound to become associated with α-synuclein aggregates, and detecting the labeled compound associated with one or more α-synuclein aggregates.
A kit for detecting α-synuclein aggregates in the brain of an individual, comprising:
- a labeled compound;
- and instructions for using the labeled compound, said instructions comprising a direction to administer to an individual a detectable amount of labeled compound;
- a direction to wait a sufficient period of time;
- and a direction to detect the labeled compound.
1 more element
Dependencies are inferred from the claim text.